Lipofermata

Description:
Lipofermata is a protein that is expressed by myeloid-derived suppressor cells (MDSCs) and has been shown to have antiviral properties. MDSCs are cells that inhibit the immune system, which can lead to increased susceptibility to infection and cancer. Lipofermata is also an inhibitor of protein synthesis, which may be responsible for attenuating tumor growth. It has been shown to inhibit kidney fibrosis in mice and insulin resistance as well as fatty acid uptake in human cells. Lipofermata also interacts with the pd-l1 receptor, which is involved in cellular transport and metastasis of cancerous cells.